[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fDWPKuTGCYbTchEkP7cNGro2kFe8kGtet4vEGU4yjDlc":8,"$fBlyOpA-ND-NCz3mVzu4S4qkf-GWe8sHlNhEJgU7ey2A":55,"$fHfx_UqzAtnCN-Wc6sagFw4xGtINjKPJiAtp8C0EY06M":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67810,868994,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//pFEvg5RWhAz8nY2H4LEJQg8PciYwf3mn.png","章霓","浙江省立同德医院","放射科","主任医师",16,0,"脑胶质瘤WHO IV级治疗相关药品的实用用药指南","","https://ystcdn.venuertc.com/venue/AI/ab98c36c-fc5b-4aa9-b306-8ae929e54434.jpg","\u003Cdiv class=\"material-article\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">脑胶质瘤WHO IV级治疗相关药品的实用用药指南\u003C/h1>\n  \u003Cdiv class=\"material-section material-intro\">\n    \u003Cp>很多人对抗肿瘤药物多少有些忌惮，尤其是涉及脑胶质瘤WHO IV级相关治疗。其实，临床常用的化疗药、放疗辅助药和支持用药都有自己的使用讲究。今天，针对这类药品，我们梳理了7个最关键的用药细节，好帮助大家在实际使用时少走弯路，安全获益。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg1\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💊\u003C/span> 01 剂型与成分：常见药品及基本特性\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：口服胶囊，常见规格为20mg、100mg、250mg等。用于辅助放疗或单独口服，方便调节剂量。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：静脉注射用溶液，常见规格为100mg/4ml与400mg/16ml。需按体重配药。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：注射剂和口服片剂，规格多为40mg/瓶、16mg/片。大多作为对症支持用药。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：注射剂或口服片，用于预防和控制化疗过程中恶心呕吐。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：静脉注射剂，起放疗防护作用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>这些药物涵盖了抗肿瘤、辅助放化疗和生活质量提升三个方面。选择哪一种，相关剂型和规格非常重要，需严格按说明书执行。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg2\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🔬\u003C/span> 02 作用机制：怎么起效？简明说明\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：为烷化剂，能干扰DNA分裂，抑制肿瘤细胞增殖（Stupp, 2005）。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：靶向血管生成关键因子VEGF，抑制新生血管生成，从而限制肿瘤生长（Friedman et al., 2009）。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：激素类药物，能快速减缓组织水肿，维护神经组织环境。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：5-HT3受体拮抗剂，通过阻断化疗引起的呕吐反射。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：通过自由基清除，减少放射损伤，保护正常组织。\u003C/li>\n    \u003C/ul>\n    \u003Cp>每种药的作用点不一样，配合应用能达到协同效果，但也对用药方案的设计和时机提出更高要求。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg3\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>⏰\u003C/span> 03 服用时间与方法：怎么用才对？\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：一般建议清晨空腹服用，配适量温水，不可嚼碎。每次用药时间固定，有助减少胃肠道反应。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：静脉点滴30-90分钟，首次用药需慢速滴注；后续加快需确保无严重不良反应。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：口服时多与餐同服以减轻胃刺激，注射剂需专业人员操作。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：化疗前半小时静脉注射，或口服；持续作用12-24小时。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：注射剂需要在放疗前15-30分钟静脉缓慢推注。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：严格按照医嘱和说明书规定的时间、方式用药，不可自行调节。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg4\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💡\u003C/span> 04 剂量调整与特殊人群：老年、肝肾功能等注意\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：肝肾功能不全患者需谨慎酌情减量，具体依据血常规和生化监测调整。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：体重变化后需重新计算剂量，老年患者常见药物相关感染和高血压风险。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：需短疗程、逐渐减量停药，老年人易出现骨质疏松。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：儿童剂量需更精确计算，高龄患者若伴心律不齐须格外警惕。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：肾功能减退者必须减量或禁用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>有位63岁男性患者，体重较轻，服用静脉化疗药物时，医生特别按体重及肝肾功能调整了剂量，有效降低了不良反应。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg5\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>⚠️\u003C/span> 05 禁忌证与用药前风险评估\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：严重骨髓抑制、严重感染、孕妇禁用。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：活动性出血、未经控制的高血压、近期手术后禁止使用。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：活动性胃溃疡、糖尿病失控、严重真菌感染患者禁用。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：先天性QT间期延长综合征及严重心律失常患者严禁使用。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：低血压患者、孕妇和肾功能衰竭禁止使用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>用药前应详细告知医生过敏史和基础健康状况，配合全面评估，降低风险。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg6\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🔗\u003C/span> 06 药物相互作用：这些组合要当心\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：与其他骨髓抑制药物（如顺铂、氟尿嘧啶等）同时使用，骨髓抑制风险显著升高；不可与强诱导或抑制肝酶药物（如苯妥英等）联用。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：与抗凝药物联用，出血风险升高；不宜与伤口愈合相关药物短期合用。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：与NSAIDs（如布洛芬）同时使用，胃肠道不良反应风险增大。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：与其他延长QT间期药物（如多种抗心律失常药）需严格避开。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：与抗高血压药物同用，可能导致血压过低。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：用药期间出现联合用药需求，要提前咨询医生或药师，避免自行叠加使用。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg7\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>❗\u003C/span> 07 常见不良反应及处理方法\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：最常见的不良反应为白细胞与血小板下降（约10-20%），如出现发热、易瘀伤或感染症状，应立即就医。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：高血压、蛋白尿、出血与伤口愈合延迟；如输注期间出现呼吸困难或严重过敏，需马上停药。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：高血压、血糖升高、情绪波动；长期大剂量使用易感染。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：便秘、头痛、罕见心律失常，如心悸需及时评估心电图。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：恶心、低血压、面部潮红，应密切监测血压并配合缓慢输注。\u003C/li>\n    \u003C/ul>\n    \u003Cp>数据表明，严格按照说明书监控的不良反应发生率较低（Stupp, 2005；Friedman et al., 2009），体验良好。\u003C/p>\n    \u003Cp>一位接受替莫唑胺化疗患者出现白细胞下降，调整剂量并加强监测后血象逐渐恢复，未出现严重并发症。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg8\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>💼\u003C/span> 08 储存方法及有效期管理\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：需避光、密封、置于25℃以下阴凉干燥处。防止儿童误服。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：冷藏2-8℃，不可冷冻，开瓶后即用。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：片剂避光干燥保存，注射液存冰箱冷藏。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：常温保存，选用原包装。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：保存于2-8℃，按批号留意有效期。\u003C/li>\n    \u003C/ul>\n    \u003Cp>放在原包装并与其他药物分开存放，更有助识别避免混用或误服。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg9\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>📝\u003C/span> 09 漏服与过量应对措施\u003C/h2>\n    \u003Cul>\n      \u003Cli>\u003Cstrong>替莫唑胺\u003C/strong>：若漏服一剂，应尽快补服，切忌加倍，不可擅自缩短间隔。若连续漏服或过量，应联系医生，密切监测血象与肝肾。\u003C/li>\n      \u003Cli>\u003Cstrong>贝伐珠单抗\u003C/strong>：漏用需尽快补充剂量，间隔不能短于2周。过量则监测心血管和肾功能。\u003C/li>\n      \u003Cli>\u003Cstrong>甲泼尼龙\u003C/strong>：漏服时次日按计划继续，过量则关注血糖、电解质、胃肠反应。\u003C/li>\n      \u003Cli>\u003Cstrong>托烷司琼\u003C/strong>：漏服一片，在下次药时补服即可，过量罕见但如有心律异常需急诊。\u003C/li>\n      \u003Cli>\u003Cstrong>氨磷汀\u003C/strong>：过量用药有较大风险，出现过敏、低血压等需立即送医，仅限专业医疗环境下处理。\u003C/li>\n    \u003C/ul>\n    \u003Cp>正确做法：不随意更改用药计划，有用药疑问主动请医生解答。\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section material-bg10\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan>🌟\u003C/span> 10 结语：安全用药的首要原则\u003C/h2>\n    \u003Cp>无论是替莫唑胺这样的重要化疗药，还是贝伐珠单抗等靶向药物，安全使用的原则都是：严格规范、合理搭配、动态监测。如果只记住一点，那就是\u003Cstrong>绝不能自行加减药量或更改用药方案\u003C/strong>。认真对待每一次用药细节，就是对疗效和安全最好的保障。\u003C/p>\n    \u003Cp>如遇任何不适，第一时间咨询专业医生，切记不要擅自停止或调整药品使用。\u003C/p>\n    \u003Cp style=\"font-style:italic; margin-top:1em;\">文献参考:\u003Cbr>\n    - Stupp, R. et al. (2005). \"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.\" The New England Journal of Medicine, 352(10), 987-996.\u003Cbr>\n    - Friedman, H. S., et al. (2009). \"Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.\" J Clin Oncol, 27(28), 4733-4740.\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-article { \n  max-width: 860px; \n  margin: 32px auto; \n  padding: 32px 22px 48px 22px; \n  background: #fafbfc; \n  border-radius: 16px; \n  font-family: 'Segoe UI', 'Microsoft Yahei', Arial, sans-serif; \n  color: #2e384d; \n  font-size: 18px;\n  line-height: 1.82;\n  box-shadow: 0 2px 16px 0 rgba(48,56,85,0.05);\n}\n\n.material-title {\n  font-size: 2.1em;\n  letter-spacing: 1.5px;\n  color: #242e47;\n  margin-bottom: 32px;\n  text-align: center;\n  font-weight: bold;\n  border-bottom: 2px solid #e6eafd;\n  padding-bottom: 18px;\n}\n\n.material-subtitle {\n  font-size: 1.37em;\n  color: #36415c;\n  background: #f3f6f9;\n  border-left: 8px solid #a1b9e6;\n  padding: 12px 16px 12px 18px;\n  margin: 32px 0 18px 0;\n  border-radius: 8px;\n  line-height: 1.4;\n  display: flex;\n  align-items: center;\n  font-weight: 600;\n  letter-spacing: 0.7px;\n}\n\n.material-section {\n  margin-bottom: 32px;\n}\n\n.material-intro {\n  background: #e7ebf4;\n  border-radius: 10px;\n  padding:20px 18px 18px 18px;\n  font-size: 1.06em;\n  margin-bottom: 30px;\n}\n.material-bg1 { \n  background:linear-gradient(90deg, #ececf6 70%, #f6f7fa 100%); \n  border-radius:8px; \n  padding:12px 22px 10px 22px;\n}\n.material-bg2 { \n  background:linear-gradient(92deg, #e6f0f6 0%, #f8fafb 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg3 { \n  background:linear-gradient(90deg, #f9f1e9 88%, #f7fafa 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg4 { \n  background:linear-gradient(120deg, #f0ede8 85%, #f3f7f8 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg5 {\n  background:linear-gradient(90deg, #fae5e8 70%, #f6f7fa 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg6 {\n  background:linear-gradient(93deg, #e5f0ee 60%, #f6f7fa 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg7 {\n  background:linear-gradient(93deg, #fbeffa 76%, #f7fafa 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg8 {\n  background:linear-gradient(93deg, #f1f4ed 66%, #f7fafa 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg9 {\n  background:linear-gradient(96deg, #eef8fa 78%, #f5f8fc 100%);\n  border-radius:8px;\n  padding:12px 22px 10px 22px;\n}\n.material-bg10 {\n  background:linear-gradient(95deg, #edf3f9 95%, #f7fafa 100%);\n  border-radius:8px;\n  padding:12px 22px 18px 22px;\n}\n.material-section ul {\n  padding-left: 25px;\n  margin-bottom: 10px;\n}\n.material-section li {\n  margin-bottom: 6px;\n  list-style-type: disc;\n}\n.material-section p {\n  margin-top: 10px;\n  margin-bottom: 8px;\n}\n@media (max-width:600px) {\n  .material-article { padding: 9px 4px 20px 4px;}\n  .material-title {font-size: 1.3em; padding-bottom: 8px;}\n  .material-subtitle { font-size:1em; padding:8px 6px 8px 6px; }\n  .material-section {padding-left:2px; padding-right:2px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"material-article\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44",578,"2025-10-13 17:45:36","脑胶质瘤, 替莫唑胺, 贝伐珠单抗, 化疗, 用药指南","本指南汇总了脑胶质瘤WHO IV级常用药品的安全使用方法和注意事项，帮助患者及家属更科学有效地进行治疗，保障疗效与安全。","2025-10-20 15:49:59",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]